AI Verdict
ICCC has stronger fundamentals based on our AI analysis.
ICCC vs IBTA Fundamental Comparison
| Metric | ICCC | IBTA |
|---|---|---|
| Revenue | $27.6M | $342.4M |
| Net Income | $-1.0M | $3.6M |
| Net Margin | -3.8% | 1.0% |
| ROE | -3.8% | 1.2% |
| ROA | -2.4% | 0.7% |
| Current Ratio | 4.26x | 1.96x |
| Debt/Equity | 0.34x | 0.00x |
| EPS | $-0.12 | $0.12 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ICCC vs IBTA: Frequently Asked Questions
Is ICCC or IBTA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ICCC has stronger fundamentals. ICCC is rated HOLD (72% confidence) while IBTA is rated HOLD (68% confidence). This is not investment advice.
How does ICCC compare to IBTA fundamentally?
IMMUCELL CORP /DE/ has ROE of -3.8% vs Ibotta, Inc.'s 1.2%. Net margins are -3.8% vs 1.0% respectively.
Which stock pays higher dividends, ICCC or IBTA?
ICCC has a dividend yield of N/A or no dividend while IBTA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ICCC or IBTA for long term?
For long-term investing, consider that ICCC has HOLD rating with 72% confidence, while IBTA has HOLD rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ICCC vs IBTA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ICCC vs IBTA, the AI consensus favors ICCC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.